Interestingly, IDH-mutant gliomas showed statistically lower FOXM1 but higher MYC mRNA levels, which nevertheless correlated with improved overall survival similar to that of IDH mutations (Figure 2A; Figure S8A), and yet the IDH-wildtype group remained the worst in survival regardless of the expression levels of these genes. The gene discussed is IDH1; the disease is glioma.